Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.

MLA

Sugimori, Makoto, et al. “Quantitative Monitoring of Circulating Tumor DNA in Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.” Cancer Science, vol. 111, no. 1, Jan. 2020, pp. 266–78. EBSCOhost, https://doi.org/10.1111/cas.14245.

APA

Sugimori, M., Sugimori, K., Tsuchiya, H., Suzuki, Y., Tsuyuki, S., Kaneta, Y., Hirotani, A., Sanga, K., Tozuka, Y., Komiyama, S., Sato, T., Tezuka, S., Goda, Y., Irie, K., Miwa, H., Miura, Y., Ishii, T., Kaneko, T., Nagahama, M., & Shibata, W. (2020). Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy. Cancer Science, 111(1), 266–278. https://doi.org/10.1111/cas.14245

Chicago

Sugimori, Makoto, Kazuya Sugimori, Hiromi Tsuchiya, Yoshimasa Suzuki, Sho Tsuyuki, Yoshihiro Kaneta, Akane Hirotani, et al. 2020. “Quantitative Monitoring of Circulating Tumor DNA in Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.” Cancer Science 111 (1): 266–78. doi:10.1111/cas.14245.